(E)-2,3-O-Isopropylidene-4,5-dideoxy-D-erythro-pent-5-enose
oxime (E)-25 and (Z)-2,3-O-isopropylidene-4,5-dideoxy-D-
erythro-pent-5-enose oxime (Z)-25
film)/cmϪ1 3416 (OH), 3067, 1721 (C᎐O), 1603, 1449, 1260,
᎐
1101, 1065, 1019, 937, 707; δH (300 MHz; CDCl3) 8.15–8.00
(7H, m, ArH, OH), 7.60–7.35 (9.7H, m, ArH, H-1E), 6.79
(0.3H, d, J1,2 5.5, H-1Z), 6.52 (0.3H, dd, J1,2 5.5, J3,2 4.0, H-2Z),
6.13 (0.3H, dd, J3,4 7.0, J3,2 4.0, H-3Z), 6.07 (0.7H, t,
J3,2 = J1,2 = 5.5, H-2E), 6.00–5.90 (2.7H, m, H-3E, H-4, H-5),
5.53–5.32 (2H, m, 2 × H-6); m/z 473 (Mϩ), 334, 308, 281, 105
(Found: Mϩ, 473.1472. C27H23NO7 requires M, 473.1474).
Treatment of aldehyde 24 (280 mg, 1.79 mmol) with hydroxy-
lamine hydrochloride (374 mg, 5.38 mmol) and pyridine (435 µl,
5.38 mmol) in ethanol (4 ml) according to the general pro-
cedure above and subsequent column chromatography (light
petroleum–ethyl acetate; 6:1) provided less polar oxime (Z)-25
(77 mg, 25%) as a white solid, mp 98 ЊC; νmax (KBr)/cmϪ1 3236
(OH), 3097, 1456, 1386, 1373, 1306, 1256, 1217, 1156; δH (300
MHz; CDCl3) 7.86 (1H, br d, OH), 6.82 (1H, d, J1,2 5.0, H-1),
5.77 (1H, m, H-4), 5.42–5.18 (2H, m, 2 × H-5), 5.31 (1H, dd,
J1,2 5.0, J3,2 7.0, H-2), 4.83 (1H, m, H-3), 1.55 (3H, s, CH3), 1.41
(3H, s, CH3); δC (75.4 MHz; CDCl3) 150.4, 133.2, 118.2, 109.6,
78.5, 72.7, 27.6, 25.2; m/z 172 (MHϩ), 156, 115, 98 (Found:
MHϩ, 172.0972. C8H14NO3 requires m/z, 172.0974); and more
polar oxime (E)-25 (174 mg, 57%) as a colourless oil; νmax (thin
film)/cmϪ1 3385 (OH), 1375, 1218, 1053; δH (300 MHz; CDCl3)
7.79 (1H, br s, OH), 7.31 (1H, d, J1,2 8.0, H-1), 5.76 (1H, m, H-
4), 5.47–5.28 (2H, m, 2 × H-5), 4.76 (1H, m, H-3), 4.69 (1H, dd,
J1,2 8.0, J3,2 7.0, H-2), 1.54 (3H, s, CH3), 1.42 (3H, s, CH3); δC
(75.4 MHz; CDCl3) 149.0, 132.2, 119.4, 110.0, 79.1, 75.9, 27.9,
25.4; m/z 172 (MHϩ), 156, 114, 98 (Found: MHϩ, 172.0975).
3,4-Di-O-benzyl-2,5,6-trideoxy-D-threo-hex-5-enose oxime 13
Treatment of aldehyde 12 (360 mg, 1.16 mmol) with hydroxy-
lamine hydrochloride (242 mg, 3.48 mmol) and pyridine (281 µl,
3.48 mmol) in ethanol (3 ml) according to the general procedure
above and subsequent column chromatography (light
petroleum–ethyl acetate; 2:1) provided oxime 13 (352 mg, 93%)
as a colourless, oily, 50:50 mixture of E and Z isomers;
νmax (thin film)/cmϪ1 3324, 3262 (OH), 3027, 2858, 1495, 1449,
1076, 927, 732, 691; δH (300 MHz; CDCl3) 7.42 (0.5H, t,
J1,2 = J1,2Ј = 6.0, H-1E), 7.38–7.25 (10H, m, ArH), 6.79 (0.5H, t,
J1,2 = J1,2Ј = 5.0, H-1Z), 5.84 (1H, m, H-5), 5.40–5.30 (2H, m,
2 × H-6), 4.76–4.56 (3H, m, 3 × CH2Ph), 4.44–4.37 (1H, m,
CH2Ph), 3.94 (1H, m, H-4), 3.75 (0.5H, m, H-3Z), 3.68 (0.5H,
m, H-3E), 2.74–2.33 (2H, 2 × H-2); δC (75.4 MHz; CDCl3) 149.7,
149.5, 138.27, 128.27, 138.22, 134.7, 134.6, 128.4, 128.0, 127.9,
127.8, 127.6, 119.6, 119.5, 82.1, 81.8, 78.9, 78.0, 73.1, 73.0, 70.7,
70.6, 31.2, 27.1, not all signals resolved; m/z 326 (M ϩ Hϩ), 325,
202, 96 (Found: MHϩ, 326.1760. C20H24NO3 requires m/z,
326.1756).
(3aR,4R,5S,6S,6aR)-4,5,6-Tribenzyloxyhexahydro-1H-
cyclopent[c]isoxazole 512a
A stirred solution of oxime 4 (87 mg, 0.20 mmol) in dry toluene
(3 ml) under nitrogen was heated at reflux for 15 h. On cooling,
the solvent was removed in vacuo to give 5 (87 mg, 100%) as a
white solid, mp 108 ЊC (from diethyl ether–hexane) (lit.,12a 104–
106 ЊC), [α]D Ϫ3 (c 0.93, CHCl3) {lit.,12a [α]D Ϫ3.6 (c 0.9)}; νmax
(KBr)/cmϪ1 3206 (NH), 3028, 2874, 1497, 1453, 1360, 1117,
1094, 1069, 1029; δH (400 MHz; C6D6) 7.46–7.12 (15H, m,
ArH), 4.99 (1H, d, J 12.0, CH2Ph), 4.90 (1H, d, J 12.0, CH2Ph),
4.88 (1H, d, J 12.0, CH2Ph), 4.76 (1H, d, J 12.0, CH2Ph), 4.59
(1H, d, J 12.0, CH2Ph), 4.52 (1H, br s, NH), 4.47 (1H, d, J 12.0,
CH2Ph), 4.07 (1H, t, J5,4 = J5,6 = 8.0, H-5), 4.00 (1H, dd, J5,6 8.0,
J6a,6 6.5, H-6), 3.70 (1H, t, J4,5 = J4,3a = 8.0, H-4), 3.65 (1H, d, J3,3Ј
8.5, H-3), 3.35 (1H, dd, J6a,3a 10.0, J6a,6 6.5, H-6a), 2.87 (1H, m,
HЈ-3), 2.49 (1H, m, H-3a); δC (100 MHz; C6D6) 139.3 (C), 139.1
(C), 138.9 (C), 128.3 (CH), 128.27 (CH), 128.24 (CH), 127.74
(CH), 127.68 (CH), 127.63 (CH), 127.5 (CH), 127.4 (CH), 127.3
(CH), 86.1 (C-5 and -6), 85.3 (C-4), 75.4 (C-3), 72.4 (CH2),
72.0 (CH2), 71.8 (CH2), 66.5 (C-6a), 49.7 (C-3a); m/z 431 (Mϩ),
340, 218, 91 (Found: Mϩ, 431.2103; C, 75.16; H, 6.72; N, 3.22%.
Calc. for C27H29NO4 M, 431.2097; C, 75.15; H, 6.77; N, 3.24%).
2,3,4-Tri-O-benzyl-5,6-dideoxy-D-lyxo-hex-5-enose oxime 17
Treatment of aldehyde 16 (168 mg, 0.40 mmol) with hydroxy-
lamine hydrochloride (84 mg, 1.21 mmol) and pyridine (98 µl,
1.24 mmol) in ethanol (0.8 ml) according to the general pro-
cedure above and subsequent column chromatography (light
petroleum–ethyl acetate; 4:1) provided oxime 17 (151 mg, 87%)
as a colourless, oily, 80:20 mixture of E and Z isomers; νmax
(thin film)/cmϪ1 3348, 3031, 2869, 1454, 1089, 1068, 697; δH (300
MHz; CDCl3) 8.80 (0.2H, br s, OHZ), 8.49 (0.8H, br s, OHE),
7.42 (0.8H, d, J1,2 8.0, H-1E), 7.37–7.16 (15H, m, ArH), 6.88
(0.2H, d, J1,2 7.0, H-1Z), 5.86 (1H, m, H-5), 5.40–5.28 (2H, m,
2 × H-6), 5.02 (0.2H, dd, J2,3 4.0, J1,2 7.0, H-2Z), 4.75–4.26
(6H, m, 6 × CH2Ph), 4.22 (0.8H, dd, J2,3 5.0, J1,2 8.0, H-2E),
4.07–3.98 (1H, m, H-4), 3.81–3.73 (1H, m, H-3); δC (75.4 MHz;
CDCl3) for major, E-isomer: 149.9 (C-1), 138.4 (C), 138.3 (C),
137.8 (C), 135.3 (C-5), 128.4 (CH), 128.3 (CH), 128.2 (CH),
128.1 (CH), 127.9 (CH), 127.8 (CH), 127.7 (CH), 127.6 (CH),
127.5 (CH), 119.2 (C-6), 82.6 (C-3), 80.6 (C-4), 76.6 (C-2), 74.8
(CH2), 70.9 (CH2), 70.8 (CH2); m/z 449 (MNH4ϩ), 432 (MHϩ),
106 (Found: MHϩ, 432.2178. C27H30NO4 requires m/z,
432.2175).
(3aR,4R,5S,6S,6aR)-4,5,6-Tribenzoyloxyhexahydro-1H-
cyclopent[c]isoxazole 8
A stirred solution of oxime 7 (456 mg, 0.96 mmol) in dry tolu-
ene (16 ml) under nitrogen was heated at reflux for 15 h. On
cooling, the solvent was removed in vacuo and the residue puri-
fied by column chromatography (light petroleum–ethyl acetate;
1:1) to provide bicycle 8 (273 mg, 60%) as a white solid, mp
207–209 ЊC (from toluene); [α]D22 Ϫ29 (c 1.09, CHCl3); νmax
(KBr)/cmϪ1 3242 (NH), 1721 (C᎐O), 1265, 1106, 702; δ (400
MHz; CDCl3) 8.15–7.95 (6H, m, ArH), 7.60–7.30 (9H, m,
ArH), 6.00 (1H, t, J5,4 = J5,6 = 8.0, H-5), 5.62–5.35 (2H, m, NH,
H-6), 5.34 (1H, dd, J4,5 8.0, J4,3a 6.0, H-4), 4.63 (1H, d, J3,3Ј 9.0,
H-3), 4.25 (1H, dd, J6a,3a 9.5, J6a,6 6.0, H-6a), 3.69 (1H, m, HЈ-3),
3.21 (1H, m, H-3a); δC (100 MHz; CDCl3) 166.2 (C), 165.6 (C),
133.5 (CH), 133.3 (CH), 133.26 (CH), 129.9 (CH), 129.87 (CH),
129.84 (CH), 129.5 (CH), 129.2 (CH), 128.5 (CH), 128.4
(CH), 128.3 (CH), 79.2 (C-4), 78.7 (C-6), 76.8 (C-5), 75.8 (C-
3), 66.0 (C-6a), 50.7 (C-3a), not all carbons resolved; m/z 473
(Mϩ), 105, 77 (Found: Mϩ, 473.1472; C, 68.35; H, 4.77; N,
2.69%. C27H23NO7 requires M, 473.1475; C, 68.49; H, 4.90; N,
2.96%).
2,3,4-Tri-O-benzyl-5,6-dideoxy-L-arabino-hex-5-enose oxime 21
Treatment of aldehyde 20 (265 mg, 0.64 mmol) with hydroxy-
lamine hydrochloride (133 mg, 1.90 mmol) and pyridine (154 µl,
1.90 mmol) in ethanol (1.3 ml) according to the general pro-
cedure above and subsequent column chromatography (light
petroleum–ethyl acetate; 6:1) provided oxime 21 (250 mg, 91%)
as a colourless, oily, 75:25 mixture of E and Z isomers; νmax
(thin film)/cmϪ1 3359 (OH), 3032, 2868, 1495, 1455, 1065, 937,
738, 692; δH (300 MHz; CDCl3) 7.42 (0.75H, d, J1,2 8.0, H-1E),
7.36–7.22 (15H, m, ArH), 6.91 (0.25H, d, J1,2 6.0, H-1Z), 5.99–
5.84 (1H, m, H-5), 5.47–5.35 (2H, m, 2 × H-6), 5.07 (0.25H, dd,
J1,2 6.0, J3,2 3.0, H-2Z), 4.75–4.36 (5H, m, 5 × CH2Ph), 4.25
(0.75H, dd, J2,3 5.0, J1,2 8.0, H-2E), 4.22–4.11 (1.25H, m, CH2Ph,
H-4Z), 4.06 (0.75H, dd, J4,5 7.5, J3,4 7.0, H-4E), 3.80 (0.25H, dd,
J2,3 3.0, J4,3 8.0, H-3Z), 3.66 (0.75H, dd, J4,3 7.0, J3,2 5.0, H-3E);
m/z 431 (Mϩ), 340, 284, 208, 91 (Found: Mϩ, 431.2092.
C27H29NO4 requires M, 431.2096).
᎐
H
J. Chem. Soc., Perkin Trans. 1, 1999, 3349–3355
3353